Research Site

Kisarazu-shi 292-8535

1 studies enrolling now · 7 studies all time

What they study most

Atherothrombosis, Cardiovascular Death, Chronic Rhinosinusitis With Nasal Polyps, Diabetic Kidney Disease, Hormone-Sensitive Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer, Myocardial Infarction, Prostate Cancer, Stroke, Type 2 Diabetes Mellitus, CKD and Albuminuria

Studies at this site

• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation — Recruiting now
• Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents — Running, not enrolling
• Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency — Running, not enrolling
• Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis — Completed
• A Phase 2b Diabetic Kidney Disease Study — Completed
• A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD — Completed
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin — Completed